Instructor of Medicine, University of Chicago Medicine
Endocrinology
Dr. Robert M. Sargis, MD
|
|
Give Review
Doctor Robert M. Sargis, MD practices Endocrinology. He attended Rush Medical College. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Robert Sargis has written publications. He has 16 publications published with PubMed. The lastest paper is: 'Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes.' Robert Sargis accepts all Medicare patients.
Publications
- Silencing Mediator of Retinoid and Thyroid Hormone Receptors (SMRT) regulates glucocorticoid action in adipocytes.
- Environmental endocrine disruption of energy Metabolism and cardiovascular risk.
- Adipocytes under assault: Environmental disruption of adipose physiology.
- The Hijacking of Cellular Signaling and the Diabetes Epidemic: Mechanisms of Environmental Disruption of Insulin Action and Glucose Homeostasis.
- The Endocrine Disrupting Chemical Tolylfluanid Alters Adipocyte Metabolism via Glucocorticoid Receptor Activation.
- The novel endocrine disruptor tolylfluanid impairs insulin signaling in primary rodent and human adipocytes through a reduction in insulin receptor substrate-1 levels.
- PCB 126 and Other Dioxin-Like PCBs Specifically Suppress Hepatic PEPCK Expression via the Aryl Hydrocarbon Receptor.
- The paradox of progress: environmental disruption of Metabolism and the diabetes epidemic.
- Environmental endocrine disruptors promote adipogenesis in the 3T3-L1 cell line through glucocorticoid receptor activation.
- Making fat work.
- Protection of membrane cholesterol by sphingomyelin against free radical-mediated oxidation.
- Trans unsaturated fatty acids are less oxidizable than cis unsaturated fatty acids and protect endogenous Lipids from oxidation in lipoproteins and Lipid bilayers.
- Spectral changes in metal halide and high-pressure sodium lamps equipped With electronic dimming.
- Sphingomyelin: a natural modulator of membrane homeostasis and inflammation.
- A 59 year-old man With sellar lesion.
Schools
Rush Med Coll Of Rush Univ
Procedures Preformed
- Continuous Glucose Monitoring
Conditions Treated
- Abnormal Thyroid
- Calcium Metabolism Disorders
- Diabetes Insipidus
- Diabetes Mellitus, Secondary
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Chicago -
Rush Medical College
Hospital
-
University of Chicago Medical Center
Drug Facts
| NPI NUMBER | 1760649990 | |
| NPPES Provider LastName | SARGIS | |
| NPPES Provider FirstName | ROBERT | |
| NPPES Provider ZIPCode | 60637 | |
| NPPES Provider State | IL | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 815.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1760649990 |
| Last Name Of The Provider | SARGIS |
| First Name Of The Provider | ROBERT |
| View All |
Similar Doctors
|
|
Dr. Bridget P. Sinnott, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald W. Sobel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Janice Gilden, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard S. Crawford, MD
This Doctor is OpenDoctor Recommended.
|